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Abstract
Background: Bacteriophage could be an alternative to conventional antibiotic therapy against multidrug-resistant bacteria.
However, the emergence of resistant variants after phage treatment limited its therapeutic application.
Methodology/Principal Findings: In this study, an approach, named ‘‘Step-by-Step’’ (SBS), has been established. This
method takes advantage of the occurrence of phage-resistant bacteria variants and ensures that phages lytic for wild-type
strain and its phage-resistant variants are selected. A phage cocktail lytic for Klebsiella pneumoniae was established by the
SBS method. This phage cocktail consisted of three phages (GH-K1, GH-K2 and GH-K3) which have different but overlapping
host strains. Several phage-resistant variants of Klebsiella pneumoniae were isolated after different phages treatments. The
virulence of these variants was much weaker [minimal lethal doses (MLD).1.3610
9 cfu/mouse] than that of wild-type K7
countpart (MLD=2.5610
3 cfu/mouse). Compared with any single phage, the phage cocktail significantly reduced the
mutation frequency of Klebsiella pneumoniae and effectively rescued Klebsiella pneumoniae bacteremia in a murine K7 strain
challenge model. The minimal protective dose (MPD) of the phage cocktail which was sufficient to protect bacteremic mice
from lethal K7 infection was only 3.0610
4 pfu, significantly smaller (p,0.01) than that of single monophage. Moreover, a
delayed administration of this phage cocktail was still effective in protection against K7 challenge.
Conclusions/Significance: Our data showed that the phage cocktail was more effective in reducing bacterial mutation
frequency and in the rescue of murine bacteremia than monophage suggesting that phage cocktail established by SBS
method has great therapeutic potential for multidrug-resistant bacteria infection.
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Introduction
Lytic bacteriophages are viruses that infect bacteria, hijack their
machinery, replicate intracellularly and are finally released by host
cell lysis [1]. From the early 1920s, phage therapy has been
considered as antimicrobial agents for the treatment of bacterial
infectious diseases. However, the development of this therapy has
been hampered by the advent of antibiotics [2]. Due to the
emergence of multidrug-resistant bacteria, phage therapy has been
resurrected during the past few decades [2,3,4]. Phage therapy
might be a viable alternative to or complement conventional
antibiotic therapy because it has already been proven to be
advantageous as these are very specific, accurate and potent than
antibiotics [5,6,7]. Another advantage of using phages over
antibiotics is that phages can replicate at the site of infection
and thus become available in abundance at the desired site [8]. In
addition, several recent and well-controlled animal studies have
demonstrated the potential of phages for antibacterial therapy
[9,10,11].
Klebsiella pneumoniae is an opportunistic pathogen frequently
associated with urinary tract, bloodstream and intra-abdominal
infections, pneumonia, and bacteremia in hospitalized persons
whose immunity is compromised by underlying diseases [12,13].
Bacteremia caused by K. pneumoniae usually leads to significant
morbidity and mortality in the general population [14]. Treatment
of these infections has become ever more difficult due to the
prevalent of multidrug-resistant strains [15,16]. Hence, there is
urgency to explore new therapeutic options.
Virulent phages specific to K. pneumoniae cells have been studied
to control the infection caused by this pathogen [15,17,18].
However, the fast emergence of resistant variants during
phage treatment is one of the most serious problems [19,20].
Previous studies have indicated that the phage cocktail can delay
the appearance of phage-resistant variants and enhance treat-
ment efficacy [21,22]. In the present study, we established a
‘‘Step-by-Step’’ (SBS) approach to isolate different phages using
wild-type isolates and consecutively phage-resistant variants as
host bacteria. The therapeutic potential of the phage cocktail
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e31698based on this method was further examined in murine model of
infection.
Results
The morphology and host range of bacteriophages
GH-K1, GH-K2 and GH-K3 were isolated using K7, K7R
1
and K7R
2 as host strains respectively by the SBS method. These
phages were examined under the Transmission Electron Micro-
scope and showed significant morphological variation (Fig. 1).
GH-K1 and GH-K3 appeared to be similar in morphology
whereas GH-K2 looked different. GH-K2 had an isometrically
hexagonal head of 6065 nm in diameter, a contractile tail
measuring 40620 nm, and a double layer baseplate of about
30 nm in diameter, to which 20-nm short tail spikes were attached.
The head was separated from the tail sheath by a collar. The
observed morphology suggested that GH-K2 was a member of the
Myovirus family. GH-K1 displayed an isometrically hexagonal head
of 4065 nm in diameter and a long tail of 18065 nm. GH-K3
had an isometrically hexagonal head of about 50 nm in diameter
and a 150-nm-long tail. In addition, the tail of GH-K3 appeared
to be more flexible compared with that of GH-K1. All phages
formed clear plaques in the early stage when cultured with K7
strain, and several hours later, the plaques became larger and were
surrounded by a large halo. The phage cocktail used in this study
was composed of these three phages.
The bacterial host range of three phages was further
investigated. All phages displayed lytic activity against K7 strain.
In addition to lyse the specific host strain, these phages were able
to lyse many other K. pneumoniae strains These phages showed a
broad host range and the host spectra were different as presented
in Table 1. More importantly, of the 34 remaining K. pneumoniae
samples tested, the combination of three phages was lytic against
30 strains. It’s also worth to mention that GH-K2 displayed lytic
ability against BAA-2146, a New Delhi metallo-b-lactamase 1
(NDM-1) producing strains. However, no lytic activity against
Streptococcus pneumoniae, Bacillus subtilis, Salmonella enteritidis, Staphylo-
coccus aureus,o rEscherichia coli was detected.
Characterization of K7 and variants
Phage-resistant strains were isolated from different bacterial
cultures in the present of phage(s) [K7R
1 from K7 cultures in the
presence of GH-K1; K7R
2 from K7R
1 cultures in the presence of
GH-K2; K7R
3 from K7R
2 cultures in the presence of GH-K3;
K7R
123 from K7 cultures in the presence of GH-K1, GH-K2 and
GH-K3]. Compared with K7, which formed large smooth
colonies, all variants formed small rough colonies. Variant strains
displayed reduced growth rate during the exponential growth
phase. The bacterial growth was monitored by measuring culture
turbidity (OD600). After incubation for 3 h, broth cultures of the
variant strains had an OD600 of #0.4 compared with that of K7
(OD600 reached 0.65 at the same condition). In addition, the broth
culture of K7 was so viscid that it’s difficult to precipitate by
centrifugation. Although the morphology of single bacteria did not
differ among the different strains under scanning electron
microscopy (SEM), most K7 cells were in the form of large
bacterial aggregates and some adhered to the thick jelly (Fig. 2),
while the variants scatterly located. This morphology feature of
variant strains remained stable even after repeated subculture and
storage at 270uC.
There was significant disparity in the MLD between K7 and
variants. The variants displayed much weaker virulence, with a
MLD.1.3610
9 cfu. In contrast, the MLD of K7 was only
2.5610
3 cfu. In addition, when 10
8 cfu variants was intraperito-
Figure 1. Morphology of phages as revealed by TEM. Three phages displayed different morphology. GH-K2 displayed a short and contractile
tail. The tails of GH-K1 and GH-K3 were long, and the tail of GH-K3 appeared more flexible than that of GH-K1. The bars represent 200 nm.
doi:10.1371/journal.pone.0031698.g001
Table 1. Susceptibility of strains to different phages.
Organism Strain Source
a Phages
GH-K1 GH-K2 GH-K3
K. pneumoniae K7 1 NNN
K7R
1 1 # N
#
K7R
2 1 N
# N
K7R
3 1 # N
#
K7R
123 1 ###
BAA-2146 2 # N
#
K01-K34 1 15N/19# 21N/13# 12N/22#
Streptococcus
pneumoniae
CVCC606 3 ###
B. subtilis EA751 1 ###
S. enteritidis CVCC541 3 ###
E. coli ATCC 25922 2 ###
S. aureus ATCC 25923 2 ###
a1: isolated from the First Hospital of Jilin University; 2: laboratory collection; 3:
purchased from China Institute of Veterinary Drug Control; 4: purchased from
American Type Culture Collection.
doi:10.1371/journal.pone.0031698.t001
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became undetectable in mice 7 days after injection, and the
infected mice didn’t show any signs of physical stress (ruffled fur or
general lethargy).
The mutation frequency was reduced by phage cocktail
When K7 were cocultured with different phage(s), there was an
increase in OD600 at the beginning. After coculture for 1–2 h, lytic
disintegration of cells resulted in a conspicuous decrease of OD600.
The phage cocktail induced a sharp decrease of OD600 from 0.5 to
0.06 within 1.5 h, while monophage treatment resulted in a much
slower decrease of OD600 from 0.6560.05 to 0.1260.04 within
2.5 h. Otherwise, normal bacterial culture in the absence of phage
showed a consistent increase in OD600 examined at different time
points. It took 6–8 h for monophage-treated bacteria or 26 h for
phage cocktail-treated bacteria to regain apparent growth. The
production of resistant variant following phage cocktail treatment
(cfu/mL 6 SD, 7.560.3610
27) was significantly less (p,0.01)
compared with monophage treatment (cfu/mL 6 SD, GH-
K1=9.560.23610
24, GH-K2=360.36610
25, GH-
K3=460.2610
24).
Phage treatment of systemic infections
To produce a murine bacteremia model, a heavy dose of K7
was administrated intraperitoneally. An acute bacteremia was
induced at a challenge dose of 2.5610
8 cfu per mouse. This
murice model was used for the phage therapy studies. Bacteremia
was detected after 30 min after K7 challenge. The bacterial count
in the blood reached 3.6610
6 cfu/mL. At this point, the bacterial
counts in heart, liver and spleen were more than 2.3610
5 and the
infection was systemic.
Different monophage and phage cocktail were injected
intraperitoneally 30 min later after K7 challenge. As shown in
Fig. 3, the MPDs of GH-K1, GH-K2, GH-K3, and cocktail were
3.0610
7, 3.0610
5, 3.0610
6, and 3.0610
4 pfu/mouse, respective-
ly. The bacterial counts in the blood decreased to 3.0610
2,
2.0610
2, and 1.1610
3 cfu/mL 2 h after treatment with GH-K1,
GH-K2, and GH-K3, respectively (Fig. 4). Importantly, bacter-
emia dropped significantly after 2 h treatment with phage cocktail,
reaching 3.6610
1 cfu/mL. The phage cocktail treated-mice were
more healthy than any monophage-treated mice (Fig. 5).
When a single injection of GH-K1, GH-K2, or GH-K3 at
3.0610
4 pfu/mouse was administered, the mice survival rates
were 0%, 40%, and 20%, respectively. The phage cocktail
significantly enhanced the protection of bacteremic mice against
lethal K7 infection (P,0.01). Even if the dose was reduced to
3.0610
3 pfu, the phage cocktail sufficiently protected four out of
the five mice tested. As controls, the heat-inactivated phage
cocktail and buffer treatment were ineffective. Moreover, the
administration of a single excess dose of phage cocktail
(3.0610
9 pfu) did not produce any adverse effects (fever or general
lethargy) 30 days after injection.
Effect of delay in treatment
A life-saving effect was also observed even when the phage
cocktail at the MPD was administered at 1 h and 2 h after K7
challenge. The mice model became generally lethargic and
hunch-backed at these time points. The protective rate also
reached 100% and 60% respectively (Fig. 6). Even when
administered at 3 h, the phage cocktail also displayed effective
protection (100%) after increasing the dose from 3.0610
4 pfu to
6.0610
6 pfu.
Figure 2. Electron micrographs of K. pneumoniae strains. A, B, and C show K7, and D shows K7R
1. B and C are higher magnification views of A.
C and D are at the same magnification. The images show that K7 adsorbed to the thick jelly and formed large bacterial aggregates.
doi:10.1371/journal.pone.0031698.g002
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Bacteriophage could be an alternative to antibiotics for the
treatment of multidrug-resistant bacterial infections. Indeed, it has
proven to be medically superior to antibiotic therapy in many ways
[23]. However, the emergence of phage-resistant variants was
observed rapidly if only one phage strain was used against a
particular bacterium [22]. Fortunately, there are an abundance of
other phage species which possess lytic ability against resistance-
obtained variants [5].
In the present study, we report a SBS method. The method
takes advantage of the occurrence of phage-resistant variants and
ensures phages lytic for wild-type strain and its phage-resistant
variants are selected. The phage cocktail established by this
method can not only display broad lytic range, but also ensure that
bacteria resistant to one phage remain susceptible to others.
Hence, the cocktail established by SBS is significantly different
from previous phage cocktails [24,25].
Three phages have been isolated using the SBS method in this
study. If cells which resistant to phage ‘‘X’’ are sensitive to phage
‘‘Y,’’ it can be concluded that the adsorption receptors or the
infection mechanism of phage ‘‘X’’ and ‘‘Y’’ are different
[26,27,28]. In this sense, GH-K1, GH-K2 and GH-K3 could
identify different receptors or possess different infection mecha-
nism.
The avirulence and reduced persistence of these variants in vivo
were in agreement with previous studies [29,30]. Perhaps, the
occurrence of this phenomenon was because the variants could be
cleared rapidly by innate immunity [31]. Otherwise, in the case of
K. pneumoniae, the virulence is related to the surface-specific
polysaccharide antigen (SPA), which acts as an initial surface
binder that helps the organisms gather together or form biofilms
[15]. Maybe, compared with K7, SPA on the variant strains might
have been changed or missed.
In most cases, the appearance of phage-resistant mutants was
not considered important as earlier studies have reported that
resistant variants tended to be avirulent and were easily taken care
by phagocytes and immune system [29,30]. However, the fast
appearance of phage-resistant variants might limit the application
of phage therapy. From the experiment in vitro, it was
demonstrated that the phage cocktail significantly reduced the
frequency of mutation compared with any monophage, and
displayed higher lytic efficacy. Although the resistant variants also
appeared when the cocktail was used, it needed a much longer
time to accumulate enough mutations to develop resistance to
three phages [28]. In addition, the long-term inhibition function
was sufficient for the immune system of mice to eliminate the small
number of avirulent variants.
More importantly, compared with any single phage, the phage
cocktail effectively rescued Klebsiella pneumoniae bacteremia in the
murine K7 strain challenge model. In addition, the dynamics of
bacteria in the blood demonstrated that the cocktail needed a
smaller dose, but displayed stronger elimination of bacteria.
Maybe, it can be concluded that the phage cocktail proliferation
threshold was higher than that of monophage in vivo [32,33].
Since, a small amount of phage cocktail can proliferate quickly,
resulted in the fast elimination of bacteria in infected mice and
lower the development of phage resistance. Coupled with the data
obtained from the experiment in vitro, it showed that these three
phages might have a synergistic effect on killing K7, at least based
on these limited studies.
In our opinion, it will be more reasonable to design
corresponding phage cocktail according to the specified pathogen.
Figure 3. Survival rate of bacteremic mice treated with different doses of phages. Mice were inoculated intraperitoneally with K7 at the
dose of 2.5610
8 cfu. Thirty minutes later, different doses of GH-K1 (#), GH-K2 (%), GH-K3 (D), or phage cocktail (e) were injected into the peritoneal
cavity of the mice. Every group contained five mice and each symbol represents the average of three experiments. The error bars indicate SD.
doi:10.1371/journal.pone.0031698.g003
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phage library (warehouse) should be established. The phage
cocktail could be formed using SBS method from the library or
medical institution and prepared in advance.
Overall, the data presented in this study showed that phage
cocktail established by SBS method has great therapeutic potential
for multidrug-resistant bacteria infection.
Materials and Methods
Animals
All animal studies were conducted according to the experimen-
tal practices and standards approved by the Animal Welfare and
Research Ethics Committee at Jilin University (Approval ID:
20110520-3). Animal experiments were carried out on 20,22 g
female BALB/c mice.
Bacterial strains and culture conditions
K7 was K. pneumoniae strain which was isolated from a clinical
specimen (obtained from a patient in the People’s Hospital of Jilin
Province, China) and showed a very strong virulence. Antimicro-
bial susceptibility tests revealed that K7 was resistant to most of the
commonly used drugs. K7R
1, K7R
2, K7R
3 and K7R
123 were
phage-resistant variants which were isolated from K7 cultures
treated by phage(s) according to the method of Verma et al. [15].
Bacteria that grew after phage treatment were isolated and re-
subjected to the same phage(s). Single bacterial colonies were
selected randomlyfrom theplate post-incubationand biochemically
verified to be K. pneumoniae. Staphylococcus aureus and Streptococcus
pneumoniae were cultured in brain heart infusion (BHI) broth, while
other strains were routinely cultured in the Luria-Bertani (LB)
medium with constant shaking (200 rpm) at 37uC for 16–18 h.
Step-by-Step (SBS) method
Step-by-Step (SBS) was an approach which isolated phages
using wild-type bacteria and consecutively phage-resistant variants
as hosts. Simply, the first and the second phages were isolated
using wild-type bacteria and the first phage-resistant variant
(resistant to the first phage) as hosts, respectively. The next variant,
resistant to the second phages, was used to isolate the third phage.
The rest could be deduced by analogy. The process of phage
isolation was stopped until the last phage-resistant bacteria were
sensitive to forward isolated phage. The cocktail comprised an
equal amount of each phage.
Figure 4. Colony counts of bacteria and titers of phages in blood samples obtained at regular intervals. The mice were challenged with
K7 at the dose of 2.5610
8 cfu. At the indicated times, bacterial counts (N) and phage titers (&) in three mice treated with either the MPD of (A)GH-
K1, (B)GH-K2, (C)GH-K3, or (D) the phage cocktail were determined from peripheral blood samples taken from the caudal vein. The arrow indicates the
moment at which the phage was injected (30 min after challenge). Each symbol represents the average of three experiments.
doi:10.1371/journal.pone.0031698.g004
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mice were treated with different single phage and phage cocktail at the MPD, while the control group was treated with PBS. The mice were scored for
their state of health on a scale of 5 to 0, based on progressive disease states. A score of 5 indicates normal health and unremarkable condition. Slight
illness, defined as decreased physical activity and ruffled fur, was scored as 4. Moderate illness, defined as lethargy and a hunched back, was scored as
3. Severe illness, with the aforementioned signs, plus exudative accumulation around partially closed eyes, was scored as 2. A moribund state was
scored as 1. Death was scored as 0. Each bar indicates the state of health of a single BALB/c mouse.
doi:10.1371/journal.pone.0031698.g005
Figure 6. Delayed treatment with phage cocktail. Mice were inoculated intraperitoneally with K7 at the dose of 2.5610
8 cfu. Cocktail phages at
the dose of 3.0610
4 pfu or a buffer were administered into the peritoneal cavities of mice at the indicated time intervals after challenging with K7.
Phage cocktail was given at 1 h (black squares), 2 h (black diamond), or 3 h (black triangles) after the K7 challenge. Infected mice treated with buffer
(white squares) under the same conditions were used as control. Each symbol represents the average of three experiments.
doi:10.1371/journal.pone.0031698.g006
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Bacteriophages active against K. pneumoniae were isolated by
using samples obtained from a Changchun sewage treatment plant
by the SBS approach. The purification of phages was achieved
according to the conventional method [34]. Different bacterio-
phages were isolated and stored in 50% glycerol at 270uC.
Purified phage samples in SM buffer [100 mM NaCl, 8 mM
MgSO4, 50 mM Tris-HCl (pH 7.5), 0.01% gelatin] were
negatively stained with phosphotungstic acid (2% w/v) and
examined by transmission electron microscopy (Hitachi Co.
Ltd., Tokyo, Japan) at an accelerating voltage of 80 kV. To
detect the host range of phages, the spot test was carried out as
described previously [35].
Comparison of K7 versus its variants
K7 and its variants were cultured on LB agar and the colony
morphology was observed. Cultures of K7 and its variants grown
to mid-exponential phase were harvested and washed twice with
PBS. Samples of these strains were visualized at 25 kV using a
JSM-5600 scanning electron microscope (JEOL Ltd., Tokyo,
Japan), after gold sputtering the specimens using a Jeol Fine Coat
JFC-1100 ion sputter coater.
Groups of five mice were injected intraperitoneally with
different bacterial inoculate to determine the minimal lethal dose
(MLD) of every strain that produces 100% mortality over a 7-day
follow-up period, as described previously [34].
The frequency of K7 mutation treated with phage(s)
Different monophage or the cocktail was added to the K7
culture at value of multiplicity of infection equal one when the
OD600 value reached 0.1. The frequency of phage resistant
variants isolation was determined as described previously [9].
Simply, cultured bacteria in liquid exposed to phage(s) were spread
plated on agar plates and the colony count was performed after
incubation at 37uC overnight. The frequency of mutation was
calculated as the number of resistant colonies/mL.
Ability of phages to protect mice against lethal K7
infection
A heavy dose of K7 (2.5610
8 cfu) was injected intraperitoneally
into groups of five mice to establish an acute bacteremic model. To
detect the state of bacteremia, the bacterial content in internal
organs and blood was observed. When the injected bacteria
effectively entered into the circulatory system, the minimal
protective dose (MPD) of single monophage and cocktail
treatment, which achieves a 100% protection rate in bacteremic
mice, was determined. Peripheral blood samples were taken from
the caudal vein and used for counting of bacterial content (cfu/
mL) and phage titer (pfu/mL) as described previously [33,36]. In
addition, the health level of infected mice with bacteria were
monitored and scored for the following manifestations indicating
progressive disease states: decreased physical activity and ruffled
fur, general lethargy and hunch-back posture, exudative accumu-
lation around partially closed eyes, moribund, and death.
Delayed-treatment experiment
To test the effect of delayed treatment on the ability of phage
cocktail to rescue the murine bacteremic model, an additional
experiment was performed. A single injection of phage cocktail
was administered to groups of five mice at different delayed time
points after K7 challenge. Protective ability was evaluated by the
protective rate.
Statistical analysis
SPSS version 13.0 (SPSS, Inc., Chicago, IL, USA) was used for
all statistical analyses. Survival rates of mice treated with phages
were analyzed using the Fisher exact test. The mutation rate was
analyzed by one-way analysis of variance. P,0.01 was considered
significant.
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